Effects of cyclosporine, prednisolone and aspirin on rat autoimmune giant cell myocarditis
S Zhang,
M Kodama,
H Hanawa,
T Izumi,
A Shibata,
and
F Masani
First Department of Internal Medicine, Niigata University School of Medicine, Japan.
OBJECTIVES. Preventive effects of cyclosporine, prednisolone and aspirin on autoimmune giant cell myocarditis in rats were investigated. BACKGROUND. The therapeutic efficacy of immunosuppressants for human myocarditis is controversial. Although harmful effects of immunosuppressive therapy on experimental viral myocarditis have been reported, the effects on autoimmune myocarditis have not been investigated. Recently, a novel experimental autoimmune myocarditis model characterized by congestive heart failure and multinucleated giant cell has been established. Using this model, the preventive effects of cyclosporine, prednisolone and aspirin on autoimmune myocarditis were investigated. METHODS. Lewis rats were immunized with cardiac myosin in complete Freund's adjuvant on days 0 and 7. In experiment 1, four groups of seven rats each were established. Rats in each group received for 21 days intraperitoneal injections of either 1) phosphate-buffered saline solution, 1 ml/day (control); 2) cyclosporine, 20 mg/kg body weight per day (cyclosporine 20); 3) prednisolone, 4 mg/kg per day; or 4) aspirin, 15 mg/kg per day. In experiment 2, two additional groups (five rats each) received for 21 days an injection of cyclosporine, 1 or 5 mg/kg per day (cyclosporine 1 and cyclosporine 5, respectively). All rats were killed on day 21, when histopathologic studies were performed and the titers of antimyosin antibodies were measured. RESULTS. The rats in the control, prednisolone and aspirin groups became ill and immobile in week 3. In comparison, rats in the cyclosporine 5 and 20 groups were still active until death was induced. Heart weight/body weight, lung weight/body weight and liver weight/body weight ratios in the rats in the cyclosporine 5 and cyclosporine 20 groups were significantly lower than those in the control group, and no differences were detectable among rats in the control, prednisolone and aspirin groups. The rats in the latter three groups and the cyclosporine 1 groups showed severe myocarditis with multinucleated giant cells. However, myocarditis was effectively prevented in the rats in the cyclosporine 5 and 20 groups. The histologic scores in each group were 2.91 in the control group, 2.14 in the prednisolone group, 2.91 in the aspirin group and 0.02, 2.58 and 0.07, respectively, in the cyclosporine 20, 1 and 5 groups. Production of antimyosin antibodies was remarkably suppressed in rats in the cyclosporine 5 and 20 groups in comparison with values in all other groups. CONCLUSIONS. Autoimmune myocarditis is preventable by cyclosporine but not by prednisolone or aspirin in usual dosages.
This article has been cited by other articles:
|
|
|
|
 
S. A Doggrell and L. Brown
Rat models of hypertension, cardiac hypertrophy and failure
Cardiovasc Res,
July 1, 1998;
39(1):
89 - 105.
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. T. Cooper, G. J. Berry, R. Shabetai, and The Multicenter Giant Cell Myocarditis Study Group
Idiopathic Giant-Cell Myocarditis -- Natural History and Treatment
N. Engl. J. Med.,
June 26, 1997;
336(26):
1860 - 1866.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Kodama, S. Zhang, H. Hanawa, M. Saeki, T. Inomata, K. Suzuki, S. Koyama, and A. Shibata
Effects of 15-Deoxyspergualin on Experimental Autoimmune Giant Cell Myocarditis of the Rat
Circulation,
February 15, 1995;
91(4):
1116 - 1122.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
O. Yokoseki, J.-i. Suzuki, H. Kitabayashi, N. Watanabe, Y. Wada, M. Aoki, R. Morishita, Y. Kaneda, T. Ogihara, H. Futamatsu, et al.
cis Element Decoy Against Nuclear Factor-{kappa}B Attenuates Development of Experimental Autoimmune Myocarditis in Rats
Circ. Res.,
November 9, 2001;
89(10):
899 - 906.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
